SGLT2 and fluid control study

SGLT2 and fluid control study - SGF Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029863

Enrollment

100

Registered

2017-11-10

Start date

2017-03-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease including diabetic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic kidney disease patients indluding diabetic kidney disease with fluid retention

Exclusion criteria

Exclusion criteria: Patients without peripheral edema, active malignancy, hemodialysis, peritoneal dialysis, patients taking some SGLT2 inhibitor and failure to cooperate with the study or provide consent to participate

Design outcomes

Primary

Measure	Time frame
Fluid volume (intracellular water and extracellular water) after 1 week, 6 months and 1 year	—

Secondary

Measure	Time frame
Renal function and cardiac function after 6 months and 1 year	—

Countries

Japan

Contacts

Public ContactTakahiro Masuda

Jichi Medical University Division of Nephrology, Department of Internal Medicine

takamasu35@gmail.com0285-58-7346

Outcome results